Delivery Order SPE2DB24D1205-SPE2DB24FCVAT

Award Date 9/25/24
Potential Completion Date 10/17/24
Potential Value $9.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,061.20 firm-fixed-price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty medication. The contract has an ultimate completion date of August 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,530.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4565456335 TEZSPIRE 210 MG/1.91 ML PEN 1.91ML medication. The contract has an ultimate completion date of September 5, 2024 and was awarded on August 14, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The $4,530.60 firm-fixed-price contract has an ultimate completion date of October 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,374.36, is a Firm Fixed Price Delivery Order for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML medical products. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This contract award is a $6,795.87 delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The order is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with an ultimate completion date of October 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,030.77, is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product, with a completion date of February 18, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 firm-fixed-price delivery order is for the supply of the medication TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a period of performance through June 5, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a $9,374.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a performance period through June 5, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,343.59 firm fixed-price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, which provides a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,687.18, is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 1, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCVAT
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $9,061.20 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of the specialty pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities from AmerisourceBergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation, and the ultimate completion date is October 17, 2024.

Generated 12/25/24, 9:21 AM